News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.



Web-based CBT noninferior for OCD in children and adolescents

By Lisa Rapaport (Reuters Health) - Children and adolescents with obsessive-compulsive disorder may respond just as well to cognitive behavioral therapy (CBT) delivered online as they would to similar

Canadian province of Ontario will pause first doses of AstraZeneca vaccine

By Reuters Staff TORONTO (Reuters) - The Canadian province of Ontario will stop offering first doses of AstraZeneca's COVID-19 vaccine because of evidence that the risk of rare blood clots is somewhat

ICU stay tied to higher risk of post-discharge suicide compared to other hospitalizations

By Marilynn Larkin NEW YORK (Reuters Health) - Admission to an intensive care unit (ICU) was associated with a higher rate of suicide and self-harm after discharge compared with hospitalizations

Low diagnostic yield with cystoscopy and CT urography for urinary tract cancers

By Lisa Rapaport (Reuters Health) - Few patients with microhematuria who undergo evaluation for urinary tract cancers with cystoscopy or computed tomographic urography are diagnosed with a malignancy,

New drug helps COVID-19 patients breathe on their own

By Reuters Staff (Reuters) - When a new monoclonal antibody drug was added to treatments being given to hospitalized COVID-19 patients who were still breathing on their own, the drug - lenzilumab from

Drug candidate for pulmonary arterial hypertension identified

By Marilynn Larkin NEW YORK (Reuters Health) - High-throughput screening combined with in silico bioinformatics analyses identified a compound that reversed blood vessel damage and halted lesion

Virus might insert genetic fragments into patients' genetic code

By Reuters Staff (Reuters) - A controversial new paper based on laboratory experiments suggests a possible explanation for why some COVID-19 survivors still test positive on viral RNA tests months

High risk of repeat stroke in patients with symptomatic carotid web

By Megan Brooks NEW YORK (Reuters Health) - A new study confirms the high risk of recurrent stroke in patients with a symptomatic carotid web, suggesting that medical management alone may not provide

Not every full-thickness macular hole needs surgical repair

By Lorraine L. Janeczko NEW YORK (Reuters Health) - Some full-thickness macular holes (FTMH) can close without surgery, according to a new case series. "We found that small holes - under 200 microns

Gene therapy fixes 48 of 50 'bubble boy' patients in new study

By Gene Emery NEW YORK (Reuters Health) - New results from the treatment of 50 children with so-called "bubble boy disease" show that the therapy succeeded in replacing the defective gene that causes

Mild COVID-19 infection unlikely to cause lasting heart damage

By Linda Carroll (Reuters Health) - MRI scans suggest that mild SARS-CoV-2 infections are unlikely to cause lasting damage to the heart, researchers report in a new UK study. An analysis of data from

Slovakia suspends use of AstraZeneca COVID-19 vaccine as a recipient dies

By Reuters Staff PRAGUE (Reuters) - Slovakia's Health Ministry said on Tuesday it was suspending the use of AstraZeneca's COVID-19 vaccine for people getting their first doses, after experts reviewed

Pandemic prompts EU drugs watchdog to simplify non-COVID processes

By Josephine Mason LONDON (Reuters) - Europe's medicines watchdog said it will simplify some of its review procedures to focus on COVID-19 treatments and vaccines as it faces a pandemic-driven surge

America's mask makers face post-pandemic meltdown

By Timothy Aeppel (Reuters) - The small U.S. manufacturers that rushed to produce face masks over the past year are now stuck with hundreds of millions of unsold face coverings because China is

UK to ban LGBT conversion therapy and provide more support

By Reuters Staff LONDON (Reuters) - Britain will move to ban conversion therapy and provide more support to those in the LGBT community who have undergone the treatment, as part of its post-pandemic

PARP inhibitor rucaparib helps shrink pancreatic tumors with mutations

By Megan Brooks NEW YORK (Reuters Health) - Most patients with pancreatic cancer and BRCA1/2 or PALB2 mutations had tumor shrinkage or no tumor growth after switching from chemotherapy to the oral

Primary and recurrent breast tumors may have different HER2 status

By Megan Brooks NEW YORK (Reuters Health) - HER2-negative primary breast tumors may evolve to express low HER2 upon relapse, highlighting the need to retest recurrent tumors for HER2 expression,

UPDATE 1-Brazil states halt vaccination of pregnant women after Rio death

(Adds AstraZeneca statement) By Eduardo Simões and Rodrigo Viga Gaier SAO PAULO/RIO DE JANEIRO (Reuters) - Brazilian states halted vaccination of pregnant women on Tuesday after a death in Rio de

WHO reviewing Seychelles COVID-19 data after fully vaccinated people test positive

By Reuters Staff NAIROBI (Reuters) - The World Health Organization said on Tuesday it was reviewing coronavirus data from Seychelles after the health ministry said more than a third of people who

Indian doctors warn against cow dung as COVID cure

By Amit Dave AHMEDABAD, India (Reuters) - Doctors in India are warning against the practice of using cow dung in the belief it will ward off COVID-19, saying there is no scientific evidence for its

Ad campaign critical of Japan's coronavirus response makes waves

By Reuters Staff TOKYO (Reuters) - A newspaper ad criticising the Japanese government's response to the nation's fourth pandemic wave was widely shared on social media on Tuesday as public concerns

EMA head sees OK for BioNTech vaccine in 12-year-olds potentially in late May

By Reuters Staff FRANKFURT (Reuters) - Pfizer and BioNTech's COVID-19 vaccine could potentially receive European approval for use in 12-year old children as early as the end of this month, the EU drug

Drained by COVID fight, some French ICU nurses strike for better pay

By Reuters Staff AULNAY-SOUS-BOIS, France (Reuters) - Intensive care medical staff exhausted by the battle against COVID-19 went on strike in some French hospitals on Tuesday to demand better pay and

Brazil states halt vaccination of pregnant women after Rio death

By Eduardo Simões and Rodrigo Viga Gaier SAO PAULO/RIO DE JANEIRO (Reuters) - Brazilian states halted vaccination of pregnant women on Tuesday after a death in Rio de Janeiro led health regulator

Pregnant COVID-19 patients have low in-hospital mortality rates

By Lisa Rapaport (Reuters Health) - Women hospitalized with COVID-19 appear to have lower mortality rates when they're pregnant than those who are not pregnant, even when they're admitted to intensive

U.S. authorizes Pfizer/BioNTech COVID vaccine for children 12 to 15

By Michael Erman (Reuters) - U.S. regulators on Monday authorized Pfizer and BioNTech's COVID-19 vaccine for use in children as young as 12, widening the country's inoculation program as vaccination

U.S. authorizes Pfizer/BioNTech COVID vaccine for children 12 to 15

By Reuters Staff (Reuters) - U.S. regulators on Monday authorized Pfizer and BioNTech's COVID-19 vaccine for use in children as young as 12, widening the country's inoculation program as vaccination

Novavax delays COVID-19 vaccine production timeline, sees filing for authorization in 3rd qtr

By Trisha Roy and Carl O'Donnell (Reuters) - Novavax Inc said on Monday production of its COVID-19 vaccine will ramp up at a slower pace than it had previously anticipated and it does not expect to

Pediatric gastroenteritis protection similar with Rotarix and RotaTeq vaccines

By Lisa Rapaport (Reuters Health) - Both vaccines for rotavirus, Rotarix and RotaTeq, provide a similar reduction in rotavirus gastroenteritis risk in children under 5 years old, a new systematic

Soft, flexible sensors can wirelessly monitor pregnant women and their fetuses

By Linda Carroll (Reuters Health) - An interdisciplinary team of scientists has developed a wireless network of three soft, flexible sensors that can measure the vital signs of a laboring mother and

Alpha-2 adrenergic agonists tied to fewer side effects when treating ADHD in young children

By Marilynn Larkin NEW YORK (Reuters Health) - Both alpha-2 adrenergic agonists and stimulants were associated with improvement in attention-deficit/hyperactivity disorder (ADHD) in preschool children

Immediate treatment of M. abscessus urged for cystic fibrosis

By Marilynn Larkin NEW YORK (Reuters Health) - An analysis of whole genome data from cystic fibrosis patients reveals how multi-drug resistant pathogens evolve and suggests that Mycobacterium

UPDATE 2-Biden administration to protect LGBT people against healthcare bias

(Adds American Medical Association, House Speaker Pelosi comment) By Doina Chiacu WASHINGTON (Reuters) - Gay and transgender people will be protected against sex discrimination in healthcare, the U.S.

U.S. FDA advisory panel to meet on COVID-19 vaccines in children

By Reuters Staff (Reuters) - The U.S. Food and Drug Administration said on Monday it will hold a meeting of its independent panel of advisers on June 10 to discuss the use of COVID-19 vaccines in

UPDATE 1-WHO classifies India variant as being of global concern

(Adds quotes, background) By Stephanie Nebehay and Emma Farge GENEVA (Reuters) - The World Health Organziation said on Monday that the coronavirus variant first identified in India last year was being

AstraZeneca reaches vaccine shipping milestone as EU sues again

By Francesco Guarascio BRUSSELS (Reuters) - AstraZeneca Plc has delivered 50 million doses of its COVID-19 vaccine to European Union countries, according to EU supply data, a milestone the company had

WHO classifies India variant as being of global concern

By Reuters Staff GENEVA (Reuters) - The World Health Organziation said on Monday that the B.1.617 variant first identified in India last year was being classified as a variant of global concern. "We

Anticoagulation common near end of life in dementia patients with AFib

By Megan Brooks NEW YORK (Reuters Health) - Anticoagulant therapy is often continued among nursing-home residents with advanced dementia and atrial fibrillation who are nearing the end of life, new

One AZ COVID-19 vaccine dose gives 80% lower death risk - English data

By Reuters Staff LONDON (Reuters) - Data from the rollout of AstraZeneca's COVID-19 vaccine shows one dose of the shot is associated with an 80% reduction in risk of death from the disease among

Blame game in Spain after street parties break out as restrictions ease

By Reuters Staff MADRID (Reuters) - The Spanish government and opposition blamed each other on Monday after crowds of mostly maskless youths partied in the streets of Madrid and Barcelona when a state

Europe dares to reopen as 200 millionth vaccine dose delivered

By Michael Gore and Estelle Shirbon MADRID/LONDON (Reuters) - As its vaccination drive reaches a third of adults and COVID-19 infections ease, Europe is starting to reopen cities and beaches, raising

'Black fungus' complication adds to India's COVID woes

By Manas Mishra and Kannaki Deka BENGALURU (Reuters) - The Indian government has told doctors to look out for signs of mucormycosis or "black fungus" in COVID-19 patients as hospitals report a rise in

UPDATE 1-Biden administration to protect LGBT people against healthcare bias

(Adds HHS statement, background on court rulings) By Reuters Staff WASHINGTON (Reuters) - Gay and transgender people will be protected against sex discrimination in healthcare, the U.S. health

Novavax combined influenza/COVID-19 vaccine shows promise in animal study

By Reuters Staff (Reuters) - Novavax Inc said on Monday its combined flu and COVID-19 vaccine produced functional antibodies against influenza and the coronavirus in a preclinical study. The company

Inovio says COVID-19 vaccine candidate safe, effective in mid-stage trial

By Reuters Staff (Reuters) - Inovio Pharmaceuticals Inc said its COVID-19 vaccine candidate was safe, well-tolerated and produced immune response against the new coronavirus in a mid-stage clinical

COVID home monitoring keeps people out of the hospital

By Megan Brooks NEW YORK (Reuters Health) - Participating in a home-monitoring program appears to help patients with COVID-19 avoid hospital admission, according to new U.S. research. "It was very

Pulsed field ablation effective against paroxysmal atrial fibrillation

By David Douglas NEW YORK (Reuters Health) - Pulsed field ablation (PFA), a new nonthermal ablation approach that preferentially ablates myocardial tissue, results in durable pulmonary vein isolation

Delaying antibiotics safe and effective for respiratory-tract infections

By Megan Brooks NEW YORK (Reuters Health) - For most patients with respiratory-tract infections, including those in higher-risk subgroups, it's likely okay to delay antibiotics, according to results

Pairing a CGRP antagonist with a triptan appears safe

By Megan Brooks NEW YORK (Reuters Health) - Concomitant use of the calcitonin gene-related peptide (CGRP)-receptor antagonist rimegepant and sumatriptan appears to be safe and well tolerated,

Biden administration to protect LGBT people against healthcare bias

By Reuters Staff WASHINGTON (Reuters) - Gay and transgender people will be protected against sex discrimination in healthcare, the U.S. health secretary said on Monday, as President Joe Biden's

Norway should exclude J&J, AstraZeneca from vaccine scheme - panel

By Terje Solsvik and Gwladys Fouche OSLO (Reuters) - Norway should exclude the COVID-19 vaccines made by AstraZeneca and Johnson & Johnson from its inoculation programme due to a risk of rare but

Taiwan fights to attend WHO meeting, but China says no

By Reuters Staff TAIPEI (Reuters) - Taiwan will fight to the end for an invitation to a World Health Organization (WHO) meeting this month, its foreign ministry said on Monday, but China said there

India turns to ex-army medics as COVID surge sparks calls for lockdown

By Abhirup Roy and Aishwarya Nair MUMBAI (Reuters) - India will recruit hundreds of former army medics to support its overwhelmed healthcare system, the defence ministry said on Sunday, as the country

Gene variants tied to reproductive aging also tied to vasomotor menopause symptoms

By Lisa Rapaport (Reuters Health) - Certain genetic variants that are associated with reproductive aging also appear linked to vasomotor symptoms of menopause, a new study suggests. Researchers

Racial differences in US maternal mortality tied to disparities in failure to rescue

By Lisa Rapaport (Reuters Health) - Much of the excess maternal mortality among Black women in the U.S. may be explained by failure to rescue from severe maternal morbidity, a new study suggests.

Blood markers may help predict delivery time

By Linda Carroll (Reuters Health) - Scientists have identified markers in blood that may indicate labor is approaching, according to a new study. Through an analysis of blood samples gathered during

Secondhand smoke exposure tied to oral cancer risk

By Lisa Rapaport (Reuters Health) - People who are exposed to secondhand smoke are more likely to develop oral cancers than their counterparts who don't have this exposure, a systematic review and

Key EU countries rebuff Biden on sharing COVID vaccine patents

By Jan Strupczewski and John Chalmers BRUSSELS (Reuters) - European countries distanced themselves on Friday from a proposal backed by U.S. President Joe Biden to waive patent rights on coronavirus

Pneumococcal vaccines safe for pregnant women with HIV

By Marilynn Larkin NEW YORK (Reuters Health) - Pneumococcal vaccines PCV-10 and PPV-23 are equally safe and immunogenic in pregnant women with HIV, although PPV-23 administration might be more

Novel compound reverses Alzheimer's disease in mice

By Marilynn Larkin NEW YORK (Reuters Health) - A newly developed compound boosted the ability of neurons to clear toxic proteins associated with Alzheimer's disease in mice and shows promise for doing

COVID-19 testing rates low among symptomatic Americans

By Ronnie Cohen (Reuters Health) - Sick Americans appear to be passing up opportunities to get tested for coronavirus and thus are likely unknowingly spreading the infection throughout their

Vedolizumab may not worsen COVID-19 outcomes in IBD patients

By Brandon May NEW YORK (Reuters Health) - Vedolizumab does not appear to worsen COVID-19 outcomes in patients with inflammatory bowel disease (IBD), according to data from the Surveillance of

EU reviews reports of Guillain-Barre syndrome after AstraZeneca's COVID-19 shot

By Reuters Staff (Reuters) - Europe's medicines regulator is reviewing reports of a rare nerve-degenerating disorder in people who received AstraZeneca's COVID-19 shots, raising fresh questions about

EU reviews reports of Guillain-Barre syndrome after AstraZeneca's COVID-19 shot

By Reuters Staff (Reuters) - Europe's medicines regulator is reviewing reports of a rare nerve-degenerating disorder in people who received AstraZeneca's COVID-19 shots, raising fresh questions about

INSIGHT-How the U.S. locked up vaccine materials other nations urgently need

By Allison Martell and Euan Rocha (Reuters) - To fight the pandemic at home, the United States gave its own vaccine manufacturers priority access to American-made materials needed to make the shots.

Pfizer-BioNTech files for U.S. approval of COVID-19 vaccine

By Ankur Banerjee (Reuters) - Pfizer Inc and German partner BioNTech SA have filed for a full U.S. approval for their COVID-19 vaccine, which is now authorized only for emergency use, the drugmakers

Senior U.S. CDC official Nancy Messonnier resigns from her position

By Reuters Staff (Reuters) - Senior health official Nancy Messonnier has resigned from her position at the U.S. Centers for Disease Control and Prevention, the agency's Director Rochelle Walensky said

U.S. CDC panel to vote on using Pfizer COVID-19 shot in adolescents

By Reuters Staff (Reuters) - An advisory panel to the U.S. Centers for Disease Control and Prevention (CDC) will meet on Wednesday to review data on the use of Pfizer Inc and partner BioNTech's COVID-

CDC reviewing higher COVID-19 death toll from independent group, considering revising official count -Walensky

By Carl O'Donnell (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) is reviewing an estimate of global COVID-19 deaths from the University of Washington that is more than double

Pressure from COVID-19 on French hospitals eases further

By Reuters Staff PARIS (Reuters) - Pressure on the French hospital system from the coronavirus pandemic eased for the fourth day in row on Friday and the number of COVID-19 deaths in hospitals was

WHO gives emergency approval to first Chinese COVID-19 vaccine, Sinopharm

By Stephanie Nebehay GENEVA (Reuters) - The World Health Organization (WHO) approved a COVID-19 vaccine from China's state-owned drugmaker Sinopharm for emergency use on Friday, a boost to Beijing's

One out of three Americans fully vaccinated for COVID-19, CDC says

By Reuters Staff (Reuters) - The United States has fully vaccinated 110,874,920 people for COVID-19 as of Friday morning, accounting for 33.4% of the population, the U.S. Centers for Disease Control

Positive antiretinal antibody tests common in patients without autoimmune retinopathy

By Lorraine L. Janeczko NEW YORK (Reuters Health) - Most patients with positive antiretinal antibody test results do not have autoimmune retinopathy, a new study suggests. Current commercial retinal

First COVID wave saw large drop in acute MI cases at NYU Langone

By Megan Brooks NEW YORK (Reuters Health) - There was a significant decline in acute myocardial infarction (AMI) patients who sought care during the peak of the COVID-19 pandemic at NYU Langone Health

Success rates for pediatric deceased-organ donation vary across U.S.

By Megan Brooks NEW YORK (Reuters Health) - In the United States, some organ-procurement organizations (OPOs) are better than others when it comes to pediatric deceased-organ-donor recruitment, and

Discontinuing oxytocin during active labor appears largely safe

By Scott Baltic NEW YORK (Reuters Health) - Routinely discontinuing oxytocin stimulation during active labor, and while electronic fetal monitoring is under way, significantly reduces the risks of

Sugary drink consumption tied to increased colorectal cancer risk in women

By Linda Carroll (Reuters Health) - Adult women who consume two or more sugary drinks per day may double their risk of developing colon cancer before age 50, a new study suggests. The analysis of more

Mobile app detects atypical gaze associated with autism in toddlers

By Lisa Rapaport (Reuters Health) - A mobile app on a smartphone or tablet can effectively identify gaze patterns toddlers that are typical of autism spectrum disorder, a new study suggests.

Increases in perivascular fibroblasts may predict survival in sporadic ALS

By Marilynn Larkin NEW YORK (Reuters Health) - In preclinical experiments, increases in brain perivascular fibroblasts - and their protein, SPP1 - predicted life expectancy more robustly than

REFILE-Combo drug blunts weight gain across schizophrenia patient subgroups

(Removes "Dr." throughout) By Megan Brooks NEW YORK (Reuters Health) - An investigational antipsychotic medication combining olanzapine and samidorphan (OLZ/SAM) mitigates weight gain across different

Vagus nerve stimulation plus rehabilitation promising for long-term post-stroke therapy

By Marilynn Larkin NEW YORK (Reuters Health) - Vagus nerve stimulation (VNS) paired with rehabilitation is a potential treatment option for individuals with moderate-to-severe arm impairment after

Older adults who use cannabis for health reasons often don't tell doctors

By Lisa Rapaport (Reuters Health) - While older adults who use cannabis for medical reasons are more than four times as likely as recreational users to tell doctors about it, a new study suggests that

Catheter ablation with mapping likely bests conventional approach to tachycardia over the long-term

By Marilynn Larkin NEW YORK (Reuters Health) - Catheter ablation of supraventricular tachycardia (SVT) using a minimal fluoroscopic approach (MFA) and electroanatomic mapping (EAM) achieved better

New PET tracer detects early hallmark of Alzheimer's disease

By Marilynn Larkin NEW YORK (Reuters Health) - A new positron emission tomography (PET) tracer called BU99008 detects reactive astrogliosis, a hallmark of Alzheimer's disease (AD) that occurs very

Judge puts hold on ruling voiding U.S. moratorium on evicting renters

By Jonathan Stempel and David Shepardson WASHINGTON (Reuters) - A federal judge on Wednesday threw out the U.S. Centers for Disease Control and Prevention's nationwide moratorium on evictions but

Intracerebral hemorrhage a new risk marker for arterial ischemic events

By Reuters Staff NEW YORK (Reuters Health) - Intracerebral hemorrhage (ICH) is associated with an increased risk for ischemic stroke and myocardial infarction and may be a "novel risk marker for

Siblings play a key role in adaptive-skills development in those with autism

By Megan Brooks NEW YORK (Reuters Health) - Siblings play a key part in adaptive-skill development among individuals with autism-spectrum disorder (ASD), according to new research. "The results

Combo drug blunts weight gain across schizophrenia patient subgroups

By Megan Brooks NEW YORK (Reuters Health) - An investigational antipsychotic medication combining olanzapine and samidorphan (OLZ/SAM) mitigates weight gain across different subgroups of patients with

Vaccine IP waiver could take months for WTO to negotiate-experts

By David Lawder WASHINGTON (Reuters) - Now that the U.S. President Joe Biden has backed a proposed waiver for COVID-19 vaccine intellectual property rights, the next stop is for the World Trade

Drugmakers say Biden misguided over vaccine patent waiver

By Stephanie Nebehay and Ludwig Burger GENEVA/FRANKFURT (Reuters) - Drugmakers on Thursday said U.S. President Joe Biden's support for waiving patents of COVID-19 vaccines could disrupt a fragile

Denmark, Norway study finds slightly raised blood clot rates after Astra COVID shot

By Kate Kelland (Reuters) - A study in Denmark and Norway has found slightly increased rates of vein blood clots among people who have had a first dose of AstraZeneca's COVID-19 vaccine, including

U.S. schools turn focus to mental health of students reeling from pandemic

By Maria Caspani and Hannah Beier OREFIELD, Pa. (Reuters) - As COVID-19 upended education during the past year, Pennsylvania middle school teacher Jennifer Lundberg often began her English lessons

Pleas for help in India as COVID-19 leaves children without carers

By Nivedita Bhattacharjee, Sethuraman N R and Chandini Monnappa BENGALURU (Reuters) - When an Indian children's rights group tracked down two boys aged 6 and 8 after it was told that their parents

UPDATE 1-Novavax vaccine shows 51% efficacy against South African variant, study finds

(Recasts top, adds context, HIV-negative cohort efficacy, expert comment) By Julie Steenhuysen CHICAGO (Reuters) - Novavax Inc's COVID-19 vaccine had efficacy of 51% against infections caused by the

Reduced kidney function tied to increased dementia risk

By Megan Brooks NEW YORK (Reuters Health) - Older adults with reduced kidney function may be an increased risk of developing dementia, according to a large population-based study from Sweden. "Even a

Novavax vaccine shows 43% efficacy against South African variant, study finds

By Julie Steenhuysen CHICAGO (Reuters) - Novavax Inc's COVID-19 vaccine had efficacy of 43% against infections caused by the South African variant in a group that included people with and without HIV,

Moderna booster increases antibodies against COVID-19 variants, early data shows

By Carl O'Donnell (Reuters) - Moderna Inc said on Wednesday early human trial data shows that a third dose of either its current COVID-19 shot or an experimental new vaccine candidate increases

Dexamethasone for nausea does not raise risk of surgical-site infections

By Gene Emery NEW YORK (Reuters Health) - Fears that dexamethasone may increase the risk of surgical-site infection when given to prevent nausea and vomiting after an operation appear to be unfounded.

Liraglutide works best for weight loss when vigorous exercise is added

By Gene Emery NEW YORK (Reuters Health) - Novo Nordisk's diabetes drug liraglutide works best as a weight-loss treatment when combined with vigorous exercise, according to the results of the EudraCT

Shorter tuberculosis regimen with moxifloxacin not inferior to 6-month treatment

By Gene Emery NEW YORK (Reuters Health) - A new rifapentine-based regimen with moxifloxacin can shorten the treatment time for drug-susceptible pulmonary tuberculosis, the authors behind a new phase-3

Pubmed articles

In order to help keep you abreast of current research we offer our PubMed feed. This section features the most recently published peer-reviewed studies in the 10 most common disease states.

Medical Jobs

Search healthcare jobs by specialty or location.


© 2021 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information